Fifth Third Bancorp Gilead Sciences, Inc. Transaction History

Fifth Third Bancorp

$27.3 Billion
Q3 2024

A detailed history of Fifth Third Bancorp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Fifth Third Bancorp holds 293,668 shares of GILD stock, worth $26 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

293,668

Previous 297,363 1.24%

Holding current value

$26 Million

Previous $20.4 Million 20.65%

% of portfolio

0.09%

Previous 0.08%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	SELL	$66.59 - $83.99 $246,050 - $310,343	-3,695 Reduced 1.24%	293,668 $24.6 Million
Q2 2024 Jul 22, 2024	SELL	$63.15 - $72.88 $1.42 Million - $1.64 Million	-22,506 Reduced 7.04%	297,363 $20.4 Million
Q1 2024 Apr 23, 2024	SELL	$71.58 - $87.29 $378,729 - $461,851	-5,291 Reduced 1.63%	319,869 $23.4 Million
Q4 2023 Jan 19, 2024	SELL	$73.27 - $83.09 $254,979 - $289,153	-3,480 Reduced 1.06%	325,160 $26.3 Million
Q3 2023 Oct 31, 2023	SELL	$73.94 - $80.67 $883,583 - $964,006	-11,950 Reduced 3.51%	328,640 $24.6 Million
Q2 2023 Jul 25, 2023	SELL	$76.01 - $86.7 $527,889 - $602,131	-6,945 Reduced 2.0%	340,590 $26.2 Million
Q1 2023 Apr 24, 2023	SELL	$77.31 - $88.08 $1.61 Million - $1.84 Million	-20,889 Reduced 5.67%	347,535 $28.8 Million
Q4 2022 Jan 25, 2023	SELL	$62.32 - $89.47 $464,595 - $666,998	-7,455 Reduced 1.98%	368,424 $0
Q3 2022 Oct 25, 2022	BUY	$59.54 - $68.01 $391,892 - $447,641	6,582 Added 1.78%	375,879 $23.2 Million
Q2 2022 Aug 04, 2022	SELL	$57.72 - $65.01 $794,054 - $894,342	-13,757 Reduced 3.59%	369,297 $22.8 Million
Q1 2022 Apr 19, 2022	SELL	$57.92 - $72.58 $975,372 - $1.22 Million	-16,840 Reduced 4.21%	383,054 $22.8 Million
Q4 2021 Feb 01, 2022	SELL	$64.88 - $73.64 $205,539 - $233,291	-3,168 Reduced 0.79%	399,894 $29 Million
Q3 2021 Oct 15, 2021	BUY	$67.69 - $73.03 $787,708 - $849,850	11,637 Added 2.97%	403,062 $28.2 Million
Q2 2021 Aug 06, 2021	SELL	$63.47 - $69.35 $1.44 Million - $1.57 Million	-22,640 Reduced 5.47%	391,425 $27 Million
Q1 2021 May 07, 2021	SELL	$60.0 - $68.46 $468,420 - $534,467	-7,807 Reduced 1.85%	414,065 $26.8 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $5.53 Million - $6.3 Million	-97,545 Reduced 18.78%	421,872 $24.6 Million
Q3 2020 Nov 09, 2020	SELL	$62.1 - $78.08 $1.58 Million - $1.99 Million	-25,499 Reduced 4.68%	519,417 $32.8 Million
Q2 2020 Aug 05, 2020	SELL	$72.34 - $84.0 $1.07 Million - $1.24 Million	-14,762 Reduced 2.64%	544,916 $41.9 Million
Q1 2020 May 05, 2020	BUY	$62.63 - $80.22 $2.6 Million - $3.33 Million	41,464 Added 8.0%	559,678 $41.8 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $3.81 Million - $4.2 Million	-61,895 Reduced 10.67%	518,214 $33.7 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $2.9 Million - $3.2 Million	-46,338 Reduced 7.4%	580,109 $36.8 Million
Q2 2019 Aug 07, 2019	SELL	$61.87 - $69.38 $4.17 Million - $4.68 Million	-67,427 Reduced 9.72%	626,447 $42.3 Million
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $558,955 - $626,176	-8,939 Reduced 1.27%	693,874 $45.1 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $5.51 Million - $7.19 Million	-91,072 Reduced 11.47%	702,813 $44 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $1.39 Million - $1.54 Million	-19,542 Reduced 2.4%	793,885 $61.3 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $8.14 Million - $9.5 Million	-125,493 Reduced 13.37%	813,427 $57.6 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $5.69 Million - $6.93 Million	-78,054 Reduced 7.68%	938,920 $70.8 Million
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $9.54 Million - $11.2 Million	-134,106 Reduced 11.65%	1,016,974 $72.9 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $5.72 Million - $6.78 Million	79,371 Added 7.41%	1,151,080 $93.3 Million
Q2 2017 Aug 11, 2017	BUY	N/A	1,071,709	1,071,709 $75.9 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Account

Fifth Third Bancorp Gilead Sciences, Inc. Transaction History